Display options
Cite
Broder S. Progress and challenges in the global effort against cancer. J Cancer Res Clin Oncol. 1991;117(4):290-4doi: 10.1007/BF01630710.
Broder, S. (1991). Progress and challenges in the global effort against cancer. Journal of cancer research and clinical oncology, 117(4), 290-4. https://doi.org/10.1007/BF01630710
Broder, S. "Progress and challenges in the global effort against cancer." Journal of cancer research and clinical oncology vol. 117,4 (1991): 290-4. doi: https://doi.org/10.1007/BF01630710
Broder S. Progress and challenges in the global effort against cancer. J Cancer Res Clin Oncol. 1991;117(4):290-4. doi: 10.1007/BF01630710. PMID: 2066349.
Copy Download .nbib Format: NLM
Share it on

J Cancer Res Clin Oncol. 1991;117(4):290-4. doi: 10.1007/BF01630710.

Progress and challenges in the global effort against cancer.

Journal of cancer research and clinical oncology

S Broder

PMID: 2066349 DOI: 10.1007/BF01630710

Abstract

The new decade has given birth to a large number of new concepts in our approach to cancer. The progress in molecular technology that occurred in the 1980's is being transferred in the 1990's to the bedside. The practical clinical application of basic science innovations is aimed at prevention and curative treatment of cancer in all of its forms, and is becoming a central theme of cancer therapeutics. The progress to date reflects a climate that fosters a unity of basic and clinical investigations, for example, where an understanding of tumor genetics or molecular immunoregulation can translate into an innovative clinical approach such as gene transfer therapy. The challenges that we face in this new decade arise in part from progress in certain areas, such as the discovery of natural products that have important antitumor activity but a limited source, or the increasing incidence in AIDS-related lymphomas that has come about from antiretroviral therapy-induced prolongation of survival for AIDS patients. There are critical challenges from a lack of progress in other areas, as well. The challenge of developing curative therapies is surpassed by the need to prevent those cancers before they arise. The challenge of prevention, as exemplified by the link between lung cancer and smoking, is of paramount importance. The ultimate challenge placed before the global oncology community is to ensure that the fruits of modern technology are available to all who need them.

Similar articles

[No authors listed]
Am J Public Health Nations Health. 1929 Aug;19(8):911-2. doi: 10.2105/ajph.19.8.911.
PMID: 18012816

[No authors listed]
Hospital (Lond 1886). 1903 Dec 26;35(900):228-229.
PMID: 29809871

[No authors listed]
Hospital (Lond 1886). 1901 Jun 01;30(766):150-151.
PMID: 29810727

[No authors listed]
Hospital (Lond 1886). 1900 Nov 17;29(738):120-121.
PMID: 29813501

[No authors listed]
Hospital (Lond 1886). 1903 Sep 05;34(884):398.
PMID: 29816219

[No authors listed]
Hospital (Lond 1886). 1901 May 25;30(765):134-135.
PMID: 29810697

Show all 37 similar articles

References

  1. J Natl Cancer Inst. 1990 Aug 1;82(15):1247-59 - PubMed
  2. Proc Natl Acad Sci U S A. 1971 Apr;68(4):820-3 - PubMed
  3. Science. 1990 Jun 8;248(4960):1230-4 - PubMed
  4. J Natl Cancer Inst. 1990 Jun 20;82(12):1016-24 - PubMed
  5. Ann Intern Med. 1983 Sep;99(3):367-79 - PubMed
  6. Proc Natl Acad Sci U S A. 1990 Jan;87(1):473-7 - PubMed
  7. Cancer Res. 1988 Jan 1;48(1):206-14 - PubMed
  8. Adv Cancer Res. 1978;28:31-61 - PubMed
  9. Science. 1988 Jul 15;241(4863):353-7 - PubMed
  10. Oncogene. 1989 Jun;4(6):725-9 - PubMed
  11. Cancer Invest. 1985;3(6):515-22 - PubMed
  12. Lancet. 1990 Feb 3;335(8684):241-6 - PubMed
  13. Nature. 1989 Dec 7;342(6250):705-8 - PubMed
  14. N Engl J Med. 1990 Aug 30;323(9):570-8 - PubMed
  15. Ann Intern Med. 1980 May;92(5):587-95 - PubMed
  16. Nature. 1983 Oct 27-Nov 2;305(5937):779-84 - PubMed
  17. Science. 1987 Dec 4;238(4832):1374-9 - PubMed
  18. N Engl J Med. 1989 Nov 23;321(21):1449-59 - PubMed
  19. J Immunol Methods. 1987 Aug 24;102(1):127-41 - PubMed
  20. Ann Intern Med. 1990 Aug 15;113(4):276-82 - PubMed
  21. Science. 1990 Nov 30;250(4985):1233-8 - PubMed
  22. Pharmacol Ther. 1984;25(1):83-125 - PubMed
  23. Am J Clin Nutr. 1991 Jan;53(1 Suppl):270S-282S - PubMed
  24. Blood. 1989 Jul;74(1):1-10 - PubMed
  25. Ann Intern Med. 1990 Aug 1;113(3):214-26 - PubMed
  26. Science. 1982 Aug 27;217(4562):801-6 - PubMed
  27. Int J Cancer. 1973 Sep 15;12(2):333-47 - PubMed
  28. Am J Pediatr Hematol Oncol. 1987 Summer;9(2):183-4 - PubMed
  29. J Natl Cancer Inst. 1988 Nov 2;80(17):1373-82 - PubMed
  30. Somatic Cell Genet. 1981 Nov;7(6):699-712 - PubMed
  31. N Engl J Med. 1984 Aug 30;311(9):565-70 - PubMed
  32. Science. 1989 Oct 27;246(4929):491-4 - PubMed
  33. N Engl J Med. 1988 Mar 10;318(10):618-22 - PubMed
  34. Cancer Treat Rep. 1976 Aug;60(8):1011-30 - PubMed
  35. Proc Natl Acad Sci U S A. 1975 Sep;72(9):3666-70 - PubMed
  36. Blood. 1986 Jan;67(1):31-6 - PubMed
  37. Proc Natl Acad Sci U S A. 1989 Jun;86(11):4244-8 - PubMed
  38. Nature. 1981 Mar 19;290(5803):261-4 - PubMed
  39. N Engl J Med. 1987 Apr 9;316(15):889-97 - PubMed
  40. Science. 1985 Apr 12;228(4696):149-54 - PubMed
  41. N Engl J Med. 1987 Oct 8;317(15):940-5 - PubMed
  42. Ann Intern Med. 1990 Oct 15;113(8):604-18 - PubMed
  43. N Engl J Med. 1988 Sep 1;319(9):525-32 - PubMed
  44. Ann Intern Med. 1988 May;108(5):744-53 - PubMed
  45. Cell. 1989 May 5;57(3):503-12 - PubMed
  46. Blood. 1987 Jul;70(1):254-63 - PubMed
  47. Am J Epidemiol. 1987 Oct;126(4):578-86 - PubMed
  48. Blood. 1981 Mar;57(3):379-94 - PubMed
  49. J Natl Cancer Inst. 1989 Oct 18;81(20):1568-71 - PubMed

MeSH terms

Publication Types